Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis
Background Cardiac hypertrophy and fibrosis are common adaptive responses to injury and stress, eventually leading to heart failure. Hypoxia signaling is important to the (patho)physiological process of cardiac remodeling. However, the role of endothelial PHD2 (prolyl‐4 hydroxylase 2)/hypoxia induci...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02dc5b7e7a6c459c88f08c898ebf63ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:02dc5b7e7a6c459c88f08c898ebf63ff |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:02dc5b7e7a6c459c88f08c898ebf63ff2021-11-16T10:22:43ZLoss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis10.1161/JAHA.121.0220772047-9980https://doaj.org/article/02dc5b7e7a6c459c88f08c898ebf63ff2021-11-01T00:00:00Zhttps://www.ahajournals.org/doi/10.1161/JAHA.121.022077https://doaj.org/toc/2047-9980Background Cardiac hypertrophy and fibrosis are common adaptive responses to injury and stress, eventually leading to heart failure. Hypoxia signaling is important to the (patho)physiological process of cardiac remodeling. However, the role of endothelial PHD2 (prolyl‐4 hydroxylase 2)/hypoxia inducible factor (HIF) signaling in the pathogenesis of cardiac hypertrophy and heart failure remains elusive. Methods and Results Mice with Egln1Tie2Cre (Tie2‐Cre‐mediated deletion of Egln1 [encoding PHD2]) exhibited left ventricular hypertrophy evident by increased thickness of anterior and posterior wall and left ventricular mass, as well as cardiac fibrosis. Tamoxifen‐induced endothelial Egln1 deletion in adult mice also induced left ventricular hypertrophy and fibrosis. Additionally, we observed a marked decrease of PHD2 expression in heart tissues and cardiovascular endothelial cells from patients with cardiomyopathy. Moreover, genetic ablation of Hif2a but not Hif1a in Egln1Tie2Cre mice normalized cardiac size and function. RNA sequencing analysis also demonstrated HIF‐2α as a critical mediator of signaling related to cardiac hypertrophy and fibrosis. Pharmacological inhibition of HIF‐2α attenuated cardiac hypertrophy and fibrosis in Egln1Tie2Cre mice. Conclusions The present study defines for the first time an unexpected role of endothelial PHD2 deficiency in inducing cardiac hypertrophy and fibrosis in an HIF‐2α–dependent manner. PHD2 was markedly decreased in cardiovascular endothelial cells in patients with cardiomyopathy. Thus, targeting PHD2/HIF‐2α signaling may represent a novel therapeutic approach for the treatment of pathological cardiac hypertrophy and failure.Zhiyu DaiJianding ChengBin LiuDan YiAnlin FengTing WangLingling AnChen GaoYibin WangMaggie M. ZhuXianming ZhangYou‐Yang ZhaoWileyarticleangiogenesiscardiac hypertrophyendothelial cellsheart failurehypoxia‐inducible factorDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
angiogenesis cardiac hypertrophy endothelial cells heart failure hypoxia‐inducible factor Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
angiogenesis cardiac hypertrophy endothelial cells heart failure hypoxia‐inducible factor Diseases of the circulatory (Cardiovascular) system RC666-701 Zhiyu Dai Jianding Cheng Bin Liu Dan Yi Anlin Feng Ting Wang Lingling An Chen Gao Yibin Wang Maggie M. Zhu Xianming Zhang You‐Yang Zhao Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis |
description |
Background Cardiac hypertrophy and fibrosis are common adaptive responses to injury and stress, eventually leading to heart failure. Hypoxia signaling is important to the (patho)physiological process of cardiac remodeling. However, the role of endothelial PHD2 (prolyl‐4 hydroxylase 2)/hypoxia inducible factor (HIF) signaling in the pathogenesis of cardiac hypertrophy and heart failure remains elusive. Methods and Results Mice with Egln1Tie2Cre (Tie2‐Cre‐mediated deletion of Egln1 [encoding PHD2]) exhibited left ventricular hypertrophy evident by increased thickness of anterior and posterior wall and left ventricular mass, as well as cardiac fibrosis. Tamoxifen‐induced endothelial Egln1 deletion in adult mice also induced left ventricular hypertrophy and fibrosis. Additionally, we observed a marked decrease of PHD2 expression in heart tissues and cardiovascular endothelial cells from patients with cardiomyopathy. Moreover, genetic ablation of Hif2a but not Hif1a in Egln1Tie2Cre mice normalized cardiac size and function. RNA sequencing analysis also demonstrated HIF‐2α as a critical mediator of signaling related to cardiac hypertrophy and fibrosis. Pharmacological inhibition of HIF‐2α attenuated cardiac hypertrophy and fibrosis in Egln1Tie2Cre mice. Conclusions The present study defines for the first time an unexpected role of endothelial PHD2 deficiency in inducing cardiac hypertrophy and fibrosis in an HIF‐2α–dependent manner. PHD2 was markedly decreased in cardiovascular endothelial cells in patients with cardiomyopathy. Thus, targeting PHD2/HIF‐2α signaling may represent a novel therapeutic approach for the treatment of pathological cardiac hypertrophy and failure. |
format |
article |
author |
Zhiyu Dai Jianding Cheng Bin Liu Dan Yi Anlin Feng Ting Wang Lingling An Chen Gao Yibin Wang Maggie M. Zhu Xianming Zhang You‐Yang Zhao |
author_facet |
Zhiyu Dai Jianding Cheng Bin Liu Dan Yi Anlin Feng Ting Wang Lingling An Chen Gao Yibin Wang Maggie M. Zhu Xianming Zhang You‐Yang Zhao |
author_sort |
Zhiyu Dai |
title |
Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis |
title_short |
Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis |
title_full |
Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis |
title_fullStr |
Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis |
title_full_unstemmed |
Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis |
title_sort |
loss of endothelial hypoxia inducible factor‐prolyl hydroxylase 2 induces cardiac hypertrophy and fibrosis |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/02dc5b7e7a6c459c88f08c898ebf63ff |
work_keys_str_mv |
AT zhiyudai lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT jiandingcheng lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT binliu lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT danyi lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT anlinfeng lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT tingwang lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT linglingan lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT chengao lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT yibinwang lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT maggiemzhu lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT xianmingzhang lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis AT youyangzhao lossofendothelialhypoxiainduciblefactorprolylhydroxylase2inducescardiachypertrophyandfibrosis |
_version_ |
1718426523334082560 |